Limits...
Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study.

Wang T, Xu Y, Xu M, Wang W, Bi Y, Lu J, Dai M, Zhang D, Ding L, Xu B, Sun J, Zhao W, Jiang Y, Wang L, Li Y, Zhang M, Lai S, Wang L, Ning G - Cardiovasc Diabetol (2015)

Bottom Line: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18 years or older in 2010, using a complex, multistage, probability sampling design.Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III.

View Article: PubMed Central - PubMed

ABSTRACT

Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population.

Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18 years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III.

Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels.

Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.

No MeSH data available.


Related in: MedlinePlus

Awareness, treatment and control of hypertension (A) and dyslipidemia (B) by glycemic status.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4356058&req=5

Fig1: Awareness, treatment and control of hypertension (A) and dyslipidemia (B) by glycemic status.

Mentions: Among all participants, the proportion of participants who were aware of hypertension, in the meanwhile received anti-hypertensive medications and had their blood pressure controlled was 2.1% (95% CI: 1.5%, 2.7%) in previously-diagnosed diabetes patients vs newly-diagnosed diabetes (1.0% [95% CI: 0.7%, 1.3%]). Treatment and control of dyslipidemia were even worse than that of hypertension. The proportion of controlled lipids and treated dyslipidemia was higher in previously-diagnosed diabetes (3.0%, 95% CI: 2.3%, 3.9%) than newly-diagnosed diabetes (0.5%, 95% CI: 0.3%, 0.8%), as well as the proportion of treated but uncontrolled patients (Figure 1).Figure 1


Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study.

Wang T, Xu Y, Xu M, Wang W, Bi Y, Lu J, Dai M, Zhang D, Ding L, Xu B, Sun J, Zhao W, Jiang Y, Wang L, Li Y, Zhang M, Lai S, Wang L, Ning G - Cardiovasc Diabetol (2015)

Awareness, treatment and control of hypertension (A) and dyslipidemia (B) by glycemic status.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4356058&req=5

Fig1: Awareness, treatment and control of hypertension (A) and dyslipidemia (B) by glycemic status.
Mentions: Among all participants, the proportion of participants who were aware of hypertension, in the meanwhile received anti-hypertensive medications and had their blood pressure controlled was 2.1% (95% CI: 1.5%, 2.7%) in previously-diagnosed diabetes patients vs newly-diagnosed diabetes (1.0% [95% CI: 0.7%, 1.3%]). Treatment and control of dyslipidemia were even worse than that of hypertension. The proportion of controlled lipids and treated dyslipidemia was higher in previously-diagnosed diabetes (3.0%, 95% CI: 2.3%, 3.9%) than newly-diagnosed diabetes (0.5%, 95% CI: 0.3%, 0.8%), as well as the proportion of treated but uncontrolled patients (Figure 1).Figure 1

Bottom Line: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18 years or older in 2010, using a complex, multistage, probability sampling design.Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III.

View Article: PubMed Central - PubMed

ABSTRACT

Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population.

Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18 years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III.

Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels.

Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.

No MeSH data available.


Related in: MedlinePlus